Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 5
Submit an article Journal homepage
290
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Immune profiling of a patient with relapsed HIV-Related and EBV-positive diffuse large B-Cell lymphoma treated with pembrolizumab

Victoria Korsosa Division of Hematology, Jewish General Hospital, Montréal, Quebec, Canada;b Departments of Medicine and Oncology, McGill University, Montreal, Quebec, CanadaView further author information
,
Alexis Valléec Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montréal, Quebec, Canada;d Cytokines and Adaptive Immunity Laboratory, Sainte-Justine Hospital University Research Center, Université de Montréal, Montréal, Quebec, CanadaView further author information
,
Ryan Ryse Department of Physiology, McGill University, Montréal, Quebec, Canada;f Faculty of Medicine and Health Sciences, McGill University, Montréal, Quebec, CanadaView further author information
,
Stephan Probstg Division of Nuclear Medicine, Jewish General Hospital, Montréal, Quebec, Canada;f Faculty of Medicine and Health Sciences, McGill University, Montréal, Quebec, CanadaView further author information
,
Svetlana Dmitrienkoh Department of Pathology, Jewish General Hospital, Montréal, Quebec, Canada;f Faculty of Medicine and Health Sciences, McGill University, Montréal, Quebec, CanadaView further author information
,
Hélène Decaluwei Department of Pediatrics, Université de Montréal, Montréal, Quebec, Canada;d Cytokines and Adaptive Immunity Laboratory, Sainte-Justine Hospital University Research Center, Université de Montréal, Montréal, Quebec, CanadaView further author information
&
Nathalie A. Johnsona Division of Hematology, Jewish General Hospital, Montréal, Quebec, Canada;b Departments of Medicine and Oncology, McGill University, Montreal, Quebec, CanadaCorrespondence[email protected]
View further author information
 show all
Pages 1256-1260 | Received 12 Oct 2021, Accepted 21 Nov 2021, Published online: 16 Dec 2021

References

  • Carbone A, Volpi CC, Gualeni AV, Gloghini A. Epstein-Barr virus associated lymphomas in people with HIV. Curr Opin HIV Aids. 2017;12(1):39–46.
  • Vockerodt M, Yap L-F, Shannon-Lowe C, et al. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol. 2015;235(2):312–322.
  • Goodman A, Patel SP, Kurzrock RP. PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas. Nat Rev Clin Oncol. 2017;14(4):203–220.
  • Gao P, Lazare C, Cao C, et al. Immune checkpoint inhibitors in the treatment of virus-associated cancers. J Hematol Oncol. 2019;12(1):58.
  • McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T cell exhaustion during chronic viral infection and cancer. Annu Rev Immunol. 2019;37:457–495.
  • Hashimoto M, Kamphorst AO, Im SJ, et al. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu Rev Med. 2018;69:301–318.
  • Graves M, Cellimarchett G, Van Zyl B, et al. Monitoring patient response to pembrolizumab with peripheral blood exhaustion marker profiles. Front Med. 2019;6:113.
  • Chen BJ, Chapuy B, Ouyang J, et al. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res. 2013;19(13):3462–3473.
  • Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443(7109):350–354.
  • Kahan SM, Wherry EJ, Zajac AJ. T cell exhaustion during persistent viral infections. Virology. 2015;479-480:180–193.
  • Beltra JC, Decaluwe H. Cytokines and persistent viral infections. Cytokine. 2016;82:4–15.
  • Fuertes Marraco SA, Neubert NJ, Verdeil G, et al. Inhibitory receptors beyond T cell exhaustion. Front Immunol. 2015;6:310.
  • Schnell A, Bod L, Madi A, et al. The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity. Cell Res. 2020;30(4):285–299.
  • Blackburn SD, Shin H, Haining WN, et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2009;10(1):29–37.
  • Epeldegui M, Conti DV, Guo Y, et al. Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL. Sci Rep. 2019;9(1):9371.
  • Anastasiadou E, Stroopinsky D, Alimperti S, et al. Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia. 2019;33(1):132–147.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.